Zimmer Biomet Holdings Inc

ZIM

Company Profile

  • Business description

    Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The company has assembled a wide array of robotic platforms, and it spun out its dental and spine businesses in 2022.

  • Contact

    345 East Main Street
    WarsawIN46580
    USA

    T: +1 574 373-3333

    E: [email protected]

    https://www.zimmerbiomet.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    17,000

Stocks News & Analysis

stocks

Reassuring organic growth for undervalued ASX share

Efficiency gains are starting to make their mark.
stocks

Big IPOs are enticing but are they good investments?

Historically, buzzy debuts have been painful for buyers.
stocks

This defensive ASX listed REIT offers a 5% yield

Solid outlook underpinned by rent uplifts and development pipeline.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,692.20144.40-1.63%
CAC 408,080.7466.09-0.81%
DAX 4025,463.81272.43-1.06%
Dow JONES (US)49,097.061,101.11-2.19%
FTSE 10010,452.6898.49-0.93%
HKSE22,393.68447.94-1.96%
NASDAQ23,879.20550.69-2.25%
Nikkei 22556,775.042,669.17-4.49%
NZX 50 Index14,140.80106.45-0.75%
S&P 5007,175.83147.80-2.02%
S&P/ASX 2008,592.40138.00-1.58%
SSE Composite Index3,515.3762.25-1.74%

Market Movers